Mark W. Geraci
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
- Cancer Research top 1%
Papers in
-
- Pulmonary Hypertension Research and Treatments 43
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 13
- Neonatal Respiratory Health Research 9
-
- RNA modifications and cancer 12
- Co-authors
- Rubin M. Tuder (24 shared papers)Carlyne D. Cool (12 shared papers)Norbert F. Voelkel (21 shared papers)Mark D. Moore (14 shared papers)Jun Wang (3 shared papers)Laurel Wright (2 shared papers)Heiko Golpon (9 shared papers)NORBERT F. VOELKEL (3 shared papers)
- Journals
- CHEST Journal (14 papers)American Journal of Respiratory and Critical Care Medicine (11 papers)American Journal of Respiratory Cell and Molecular Biology (7 papers)Cancer Prevention Research (5 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (5 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mark W. Geraci
121 papers receiving 8.1k citations
Mark W. Geraci's Hit Papers
Peers
Comparison fields: 5 of 138
- Pulmonary and Respiratory Medicine 4.0k
- Cancer Research 1.1k
- Cardiology and Cardiovascular Medicine 1.3k
- Critical Care and Intensive Care Medicine 243
- Genetics 471
Countries citing papers authored by Mark W. Geraci
This map shows the geographic impact of Mark W. Geraci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Geraci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Geraci more than expected).
Fields of papers citing papers by Mark W. Geraci
This network shows the impact of papers produced by Mark W. Geraci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Geraci. The network helps show where Mark W. Geraci may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark W. Geraci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis Hit paper breakdown → | 2012 | 659 |
| 2 | Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension Hit paper breakdown → | 1999 | 608 |
| 3 | Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis Hit paper breakdown → | 2001 | 393 |
| 4 | Genetics and Genomics of Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 359 |
| 5 | 2000 | 338 | |
| 6 | 2009 | 267 | |
| 7 | 2005 | 244 | |
| 8 | 2003 | 243 | |
| 9 | 2001 | 219 | |
| 10 | 2004 | 205 | |
| 11 | 2003 | 204 | |
| 12 | 1998 | 179 | |
| 13 | 2004 | 172 | |
| 14 | 1999 | 166 | |
| 15 | 2014 | 136 | |
| 16 | 2007 | 133 | |
| 17 | 2002 | 125 | |
| 18 | 2004 | 120 | |
| 19 | Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. | 2002 | 117 |
| 20 | 2010 | 113 |
About Mark W. Geraci
Mark W. Geraci is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Pharmacology, having authored 124 papers that have together received 8.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (43 papers), Inflammatory mediators and NSAID effects (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Neonatal Respiratory Health Research (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.0k citations), Cancer Research (1.1k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Critical Care and Intensive Care Medicine (243 citations) and Genetics (471 citations). Mark W. Geraci has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Rubin M. Tuder, Carlyne D. Cool, Norbert F. Voelkel, Mark D. Moore, Jun Wang, Laurel Wright, Heiko Golpon, NORBERT F. VOELKEL, Christopher D. Coldren and Raphael A. Nemenoff. Their work appears in journals such as CHEST Journal, American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, Cancer Prevention Research and American Journal of Physiology-Lung Cellular and Molecular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.